Creon

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Pancreatin 300mg (9,000U amylase/8000U lipase/210U total protease)

Disponible depuis:

Boehringer Ingelheim (NZ) Ltd

DCI (Dénomination commune internationale):

Pancreatin 300 mg (9,000U amylase/8000U lipase/210U total protease)

Dosage:

300 mg

forme pharmaceutique:

Modified release capsule

Composition:

Active: Pancreatin 300mg (9,000U amylase/8000U lipase/210U total protease) Excipient: Dibutyl phthalate Dimeticone Gelatin   Hypromellose phthalate Iron oxide black Iron oxide red Iron oxide yellow   Light liquid paraffin Macrogol 4000 Titanium dioxide

Unités en paquet:

Blister pack,

classe:

General sale

Type d'ordonnance:

General sale

Fabriqué par:

Abbott Laboratories GmbH

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, -   - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 24 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

1990-02-22